Your browser doesn't support javascript.
loading
Protease-activated receptor 2 activation induces behavioural changes associated with depression-like behaviour through microglial-independent modulation of inflammatory cytokines.
Moudio, Serge; Willis, Ashleigh; Pytka, Karolina; Abulkassim, Roua; Brett, Ros R; Webster, Jack F; Wozny, Christian; Barbour, Mark; Jiang, Hui-Rong; Watson, David G; van Kralingen, Josie C; MacKenzie, Scott M; Daniels, Michael; McColl, Barry W; Sossick, Sandra; Nuthall, Hugh N; Bushell, Trevor J.
Afiliación
  • Moudio S; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
  • Willis A; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
  • Pytka K; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
  • Abulkassim R; Department of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688, Krakow, Poland.
  • Brett RR; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
  • Webster JF; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
  • Wozny C; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
  • Barbour M; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
  • Jiang HR; MSH Medical School Hamburg, Medical University, Am Kaiserkai 1, 20457, Hamburg, Germany.
  • Watson DG; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
  • van Kralingen JC; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
  • MacKenzie SM; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
  • Daniels M; Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
  • McColl BW; Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
  • Sossick S; UK Dementia Research Institute at The University of Edinburgh, Edinburgh Medical School, The Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.
  • Nuthall HN; UK Dementia Research Institute at The University of Edinburgh, Edinburgh Medical School, The Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.
  • Bushell TJ; Eli Lilly and Co. Ltd.8 Arlington Square, Bracknell, RG12 1WA, UK.
Psychopharmacology (Berl) ; 239(1): 229-242, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34888704
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Microglía / Trastorno Depresivo Mayor Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Psychopharmacology (Berl) Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Microglía / Trastorno Depresivo Mayor Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Psychopharmacology (Berl) Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido